Microtubule actin crosslinking factor 1 (MACF1) is a large spectraplakin protein known to have crucial roles in regulating cytoskeletal dynamics, cell migration, growth, and differentiation. However, its role and action mechanism in bone remain unclear. The present study investigated optimal conditions for effective transfection of the large plasmid PEGFP-C1A-ACF7 (∼21 kbp) containing full-length human MACF1 cDNA, as well as the potential role of MACF1 in bone formation. To enhance MACF1 expression, the plasmid was transfected into osteogenic cells by electroporation in vitro and into mouse calvaria with nanoparticles. Then, transfection efficiency, osteogenic marker expression, calvarial thickness, and bone formation were analyzed. Notably, MACF1 overexpression triggered a drastic increase in osteogenic gene expression, alkaline phosphatase activity, and matrix mineralization in vitro. Mouse calvarial thickness, mineral apposition rate, and osteogenic marker protein expression were significantly enhanced by local transfection. In addition, MACF1 overexpression promoted β-catenin expression and signaling. In conclusion, MACF1 overexpression by transfecting the large plasmid containing full-length MACF1 cDNA promotes osteoblast differentiation and bone formation via β-catenin signaling. Current data will provide useful experimental parameters for the transfection of large plasmids and a novel strategy based on promoting bone formation for prevention and therapy of bone disorders.
LeungCL, GreenKJ, LiemRK. Plakins: a family of versatile cytolinker proteins. Cell Biol, 2002; 12:37–45.
3.
KodamaA, KarakesisoglouI, WongE, et al.ACF7: an essential integrator of microtubule dynamics. Cell, 2003; 115:343–354.
4.
YueJ, ZhangY, LiangWG, et al.In vivo epidermal migration requires focal adhesion targeting of ACF7. Nat Commun, 2016; 7:11692.
5.
Sanchez-SorianoN, TravisM, Dajas-BailadorF, et al.Mouse ACF7 and drosophila short stop modulate filopodia formation and microtubule organisation during neuronal growth. J Cell Sci, 2009; 122:2534–2542.
6.
HuL, SuP, LiR, et al.Isoforms, structures, and functions of versatile spectraplakin MACF1. BMB reports, 2016; 49:37–44.
7.
WuX, KodamaA, FuchsE. ACF7 regulates cytoskeletal-focal adhesion dynamics and migration and has ATPase activity. Cell, 2008; 135:137–148.
8.
WuX, ShenQT, OristianDS, et al.Skin stem cells orchestrate directional migration by regulating microtubule-ACF7 connections through GSK3beta. Cell, 2011; 144:341–352.
9.
SonnenbergA, LiemRK. Plakins in development and disease. Exp Cell Res, 2007; 313:2189–2203.
10.
BouameurJE, FavreB, BorradoriL. Plakins, a versatile family of cytolinkers: roles in skin integrity and in human diseases. J Invest Dermatol, 2014; 134:885–894.
11.
LiangY, ShiC, YangJ, et al.ACF7 regulates colonic permeability. Int J Mol Med, 2013; 31:861–866.
12.
HuL, XiaoY, XiongZ, et al.MACF1, versatility in tissue-specific function and in human disease. Semin Cell Dev Biol, 2017; 69:3–8.
13.
HuL, SuP, LiR, et al.Knockdown of microtubule actin crosslinking factor 1 inhibits cell proliferation in MC3T3-E1 osteoblastic cells. BMB Rep, 2015; 48:583–588.
14.
QianAR, HuLF, GaoX, et al.Large gradient high magnetic field affects the association of MACF1 with actin and microtubule cytoskeleton. Bioelectromagnetics, 2009; 30:545–555.
YinC, ZhangY, HuL, et al.Mechanical unloading reduces microtubule actin crosslinking factor 1 expression to inhibit beta-catenin signaling and osteoblast proliferation. J Cell Physiol, 2017; 8.
17.
ChenHJ, LinCM, LinCS, et al.The role of microtubule actin cross-linking factor 1 (MACF1) in the Wnt signaling pathway. Genes Devel, 2006; 20:1933–1945.
18.
KarnerCM, LongF. Wnt signaling and cellular metabolism in osteoblasts. Cell Mol Life Sci, 2017; 74:1649–1657.
19.
FassettJT, XuX, KwakD, et al.Microtubule actin cross-linking factor 1 regulates cardiomyocyte microtubule distribution and adaptation to hemodynamic overload. PLoS One, 2013; 8:e73887.
20.
NovakovaJ, IzsakovaA, GrivalskyT, et al.Improved method for high-efficiency electrotransformation of Escherichia coli with the large BAC plasmids. Folia Microbiol (Praha), 2014; 59:53–61.
21.
CampeauP, ChapdelaineP, Seigneurin-VeninS, et al.Transfection of large plasmids in primary human myoblasts. Gene Ther, 2001; 8:1387–1394.
22.
MuroskiME, CarnevaleKJ, RiskowskiRA, et al.Plasmid transfection in mammalian cells spatiotemporally tracked by a gold nanoparticle. ACS Nano, 2015; 9:124–133.
23.
LindbergMF, Le GallT, CarmoyN, et al.Efficient in vivo transfection and safety profile of a CpG-free and codon optimized luciferase plasmid using a cationic lipophosphoramidate in a multiple intravenous administration procedure. Biomaterials, 2015; 59:1–11.
24.
ZhangJ, GuoS, ZhangW, et al.Large-pore mesoporous silica nanospheres as vehicles for delivering TRAF3-shRNA plasmids to Kupffer cells. Biochem Biophys Res Commun, 2016; 469:196–202.
25.
NormanA, RiberL, LuoW, et al.An improved method for including upper size range plasmids in metamobilomes. PLoS One, 2014; 9:e104405.
26.
BaoQ, ChenS, QinH, et al.Constitutive beta-catenin activation in osteoblasts impairs terminal osteoblast differentiation and bone quality. Exp Cell Res, 2017; 350:123–131.
27.
MargaronY, FradetN, CoteJF. ELMO recruits actin cross-linking family 7 (ACF7) at the cell membrane for microtubule capture and stabilization of cellular protrusions. J Biol Chem, 2013; 288:1184–1199.
28.
NoordstraI, LiuQ, NijenhuisW, et al.Control of apico–basal epithelial polarity by the microtubule minus-end-binding protein CAMSAP3 and spectraplakin ACF7. J Cell Sci, 2016; 129:4278–4288.
29.
YangJ, YangY. Plasmid size can affect the ability of Escherichia coli to produce high-quality plasmids. Biotechnol Lett, 2012; 34:2017–2022.
30.
LesueurLL, MirLM, AndreFM. Overcoming the specific toxicity of large plasmids electrotransfer in primary cells in vitro. Mol Ther Nucleic Acids, 2016; 5:e291.
31.
ShengY, MancinoV, BirrenB. Transformation of Escherichia coli with large DNA molecules by electroporation. Nucleic Acids Res, 1995; 23:1990–1996.
32.
RobertMA, NassouryN, ChahalPS, et al.Gene transfer of ZMapp antibodies mediated by recombinant adeno-associated virus protects against Ebola infections. Hum Gene Ther, 2017Nov27 [Epub ahead of print]; DOI: 10.1089/hum.2017.101.
33.
KretzmannJA, HoD, EvansCW, et al.Synthetically controlling dendrimer flexibility improves delivery of large plasmid DNA. Chem Sci, 2017; 8:2923–2930.
34.
PeisterA, MelladJA, WangM, et al.Stable transfection of MSCs by electroporation. Gene Ther, 2004; 11:224–228.
35.
WieseM, CastiglioneK, HenselM, et al.Small interfering RNA (siRNA) delivery into murine bone marrow–derived macrophages by electroporation. J Immunol Methods, 2010; 353:102–110.
36.
LojkJ, MisK, PirkmajerS, et al.siRNA delivery into cultured primary human myoblasts—optimization of electroporation parameters and theoretical analysis. Bioelectromagnetics, 2015; 36:551–563.
DahlmanJE, BarnesC, KhanOF, et al.In vivo endothelial siRNA delivery using polymeric nanoparticles with low molecular weight. Nat Nanotechnol, 2014; 9:648–655.
WangQ, ChenY, WangL, et al.Stability and toxicity of empty or gene-loaded lipopolysaccharide-amine nanopolymersomes. Int J Nanomed, 2015; 10:597–608.
41.
ShaoZ, ShaoJ, TanB, et al.Targeted lung cancer therapy: preparation and optimization of transferrin-decorated nanostructured lipid carriers as novel nanomedicine for co-delivery of anticancer drugs and DNA. Int J Nanomed, 2015; 10:1223–1233.
42.
QiaoC, ZhangK, SunB, et al.Sustained release poly (lactic-co-glycolic acid) microspheres of bone morphogenetic protein 2 plasmid/calcium phosphate to promote in vitro bone formation and in vivo ectopic osteogenesis. Am J Transl Res, 2015; 7:2561–2572.
43.
CoccoE, DengY, ShapiroEM, et al.Dual-targeting nanoparticles for in vivo delivery of suicide genes to chemotherapy-resistant ovarian cancer cells. Mol Cancer Ther, 2017; 16:323–333.
44.
MuthiahM, ParkIK, ChoCS. Nanoparticle-mediated delivery of therapeutic genes: focus on miRNA therapeutics. Expert Opin Drug Deliv, 2013; 10:1259–1273.
45.
HsuSH, YuB, WangX, et al.Cationic lipid nanoparticles for therapeutic delivery of siRNA and miRNA to murine liver tumor. Nanomedicine, 2013; 9:1169–1180.
46.
HadjicharalambousC, KozlovaD, SokolovaV, et al.Calcium phosphate nanoparticles carrying BMP-7 plasmid DNA induce an osteogenic response in MC3T3-E1 pre-osteoblasts. J Biomed Mater Res A, 2015; 103:3834–3842.
47.
WanQ, SchoenmakerT, JansenIDC, et al.Osteoblasts of calvaria induce higher numbers of osteoclasts than osteoblasts from long bone. Bone, 2016; 86:10–21.
48.
AndersenMO, NygaardJV, BurnsJS, et al.siRNA nanoparticle functionalization of nanostructured scaffolds enables controlled multilineage differentiation of stem cells. Mol Ther, 2010; 18:2018–2027.
49.
YanJ, ZhangC, ZhaoY, et al.Non-viral oligonucleotide antimiR-138 delivery to mesenchymal stem cell sheets and the effect on osteogenesis. Biomaterials, 2014; 35:7734–7749.
50.
LiD, ChenZ, LiuZet al.Qiang Gu Kang Wei prescription increases bone mineral density of load-bearing bone in tail suspended rats. Space Med Med Eng (Beijing), 2016; 29:8.
51.
UmebayashiM, SumitaY, KawaiY, et al.Gene-activated matrix comprised of atelocollagen and plasmid DNA encoding BMP4 or Runx2 promotes rat cranial bone augmentation. Biores Open Access, 2015; 4:164–174.
52.
DuanP, BonewaldLF. The role of the wnt/β-catenin signaling pathway in formation and maintenance of bone and teeth. Int J Biochem Cell Biol, 2016; 77:23–29.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
